MGO One Seven’s iShares Biotechnology ETF IBB Stock Holding History

MGO One Seven’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$352K	Buy	+1,853	New	+$318K	0.01%	1162
2026 Q1	–	Sell	-1,387	Closed	-$234K	–	1451
2025 Q4	$234K	Buy	+1,387	New	+$225K	﹤0.01%	1238
2023 Q2	–	Sell	-5,711	Closed	-$738K	–	846
2023 Q1	$738K	Buy	+5,711	New	+$748K	0.05%	363
2019 Q1	–	Sell	-45	Closed	-$4K	–	968
2018 Q4	$4K	Buy	+45	New	+$4.78K	﹤0.01%	1417
2018 Q1	$5K	Hold	45	–	–	﹤0.01%	1304
2017 Q4	$5K	Buy	+45	New	+$4.81K	﹤0.01%	1306

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

MGO One Seven's IBB Position: Q2 2026 in Review

MGO One Seven opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 1,853 shares worth $352K. The stake represents 0.01% of the portfolio and ranks #1162 among its holdings. This is a return to the name: MGO One Seven previously reported a position in IBB as recently as Q4 2025.

MGO One Seven first reported a position in IBB in Q4 2017 and has held it in 6 quarters since. The position peaked at $738K in Q1 2023. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

MGO One Seven held 1,853 shares of iShares Biotechnology ETF worth $352K as of Q2 2026.
iShares Biotechnology ETF was a new MGO One Seven position in Q2 2026.
iShares Biotechnology ETF made up 0.01% of MGO One Seven's portfolio in Q2 2026, its #1162 holding.
MGO One Seven first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 6 quarters since.
MGO One Seven's iShares Biotechnology ETF position peaked at $738K in Q1 2023.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.